Skip to content

Clinical trials

Phase 2 Pancreatic Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Diseases Phase: Phase 2 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20093
20101
20111
20121
20172
20201
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated3
NanOlogy, LLC2
Agensys, Inc.1
Aimmune Nestlé Health Science US R&D, LLC1
Astellas Pharma Inc1
Rezolute1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
Thomas Jefferson University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Diseases11
Digestive System Diseases6
Pancreatic Neoplasms6
Cystic Fibrosis4
Digestive System Neoplasms4
Genetic Diseases, Inborn3
Infant, Newborn, Diseases3
Lung Diseases3
Carcinoma, Pancreatic Ductal2
Fibrosis2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.